Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Tiago M. de Carvalho"'
Autor:
Partha Basu, Rengaswamy Sankaranarayanan, Ishu Kataria, Johannes Berkhof, Eric Lucas, Lopamudra Ray Saraswati, Iacopo Baussano, Richard Muwonge, Johannes A Bogaards, Tiago M de Carvalho, Irene Man, Damien Georges, Prince Bhandari, Mariam Siddiqui
Publikováno v:
BMJ Global Health, Vol 8, Iss 11 (2023)
Background Cervical cancer is a major public health problem in India, where access to prevention programmes is low. The WHO-Strategic Advisory Group of Experts recently updated their recommendation for human papillomavirus (HPV) vaccination to includ
Externí odkaz:
https://doaj.org/article/2ed21aa7ad664d4086bb34c6a82af48c
Autor:
Irene Man, Damien Georges, Tiago M de Carvalho, Lopamudra Ray Saraswati, Prince Bhandari, Ishu Kataria, Mariam Siddiqui, Richard Muwonge, Eric Lucas, Johannes Berkhof, Rengaswamy Sankaranarayanan, Johannes A Bogaards, Partha Basu, Iacopo Baussano
Publikováno v:
Man, I, Georges, D, de Carvalho, T M, Ray Saraswati, L, Bhandari, P, Kataria, I, Siddiqui, M, Muwonge, R, Lucas, E, Berkhof, J, Sankaranarayanan, R, Bogaards, J A, Basu, P & Baussano, I 2022, ' Evidence-based impact projections of single-dose human papillomavirus vaccination in India : a modelling study ', Lancet Oncology, vol. 23, no. 11, pp. 1419-1429 . https://doi.org/10.1016/S1470-2045(22)00543-5
Lancet Oncology, 23(11), 1419-1429. Lancet Publishing Group
Lancet Oncology, 23(11), 1419-1429. Lancet Publishing Group
BACKGROUND: Despite the high burden of cervical cancer, access to preventive measures remains low in India. A single-dose immunisation schedule could facilitate the scale-up of human papillomavirus (HPV) vaccination, contributing to global eliminatio
Autor:
Veerle M.H. Coupé, Hendrik Koffijberg, Joost van Rosmalen, Harold B. Wolff, Tiago M. de Carvalho
Publikováno v:
de Carvalho, T M, van Rosmalen, J, Wolff, H B, Koffijberg, H & Coupé, V M H 2022, ' Choosing a Metamodel of a Simulation Model for Uncertainty Quantification ', Medical Decision Making, vol. 42, no. 1, pp. 28-42 . https://doi.org/10.1177/0272989X211016307
Medical Decision Making, 42(1), 28-42. SAGE Publications Inc.
Medical Decision Making, 42(1), 28-42. SAGE Publishing
Medical decision making, 42(1), 28-42. SAGE Publications
Medical Decision Making, 42(1), 28-42. SAGE Publications Inc.
Medical Decision Making, 42(1), 28-42. SAGE Publishing
Medical decision making, 42(1), 28-42. SAGE Publications
Background Metamodeling may substantially reduce the computational expense of individual-level state transition simulation models (IL-STM) for calibration, uncertainty quantification, and health policy evaluation. However, because of the lack of guid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::856883832edeaf51e18f7bc7706e3a53
https://research.vumc.nl/en/publications/67ddc060-0fdd-4879-9660-f726d0c30c24
https://research.vumc.nl/en/publications/67ddc060-0fdd-4879-9660-f726d0c30c24
Publikováno v:
Cancer. 124:507-513
BACKGROUND Because of the recent grade C draft recommendation by the US Preventive Services Task Force (USPSTF) for prostate cancer screening between the ages of 55 and 69 years, there is a need to determine whether this could be cost-effective in a
Autor:
Eric J. Feuer, Eveline A.M. Heijnsdijk, Paul F. Pinsky, Ruth Etzioni, Jonas Hugosson, Vera Nelen, Arnauld Villers, Marco Zappa, Alexander Tsodikov, Roman Gulati, Tiago M. de Carvalho, Maciej Kwiatkowski, E. David Crawford, Harry J. de Koning, Marcos Lujan, Christine D. Berg, Anssi Auvinen, Sue Moss, Monique J. Roobol, Angela B. Mariotto, Gerald L. Andriole
Publikováno v:
Cancer. 124:1197-1206
Background The European Randomized Study of Screening for Prostate Cancer (ERSPC) demonstrated that prostate-specific antigen (PSA) screening significantly reduced prostate cancer mortality (rate ratio, 0.79; 95% confidence interval, 0.69-0.91). The
Autor:
Martin Eklund, Harry J. de Koning, Vera Nelen, Markus Graefen, Xavier Castells, Chris H. Bangma, Henrik Grönberg, Josep A. Espinàs, Franz Recker, Eveline A.M. Heijnsdijk, Iris Lansdorp-Vogelaar, Tiago M. de Carvalho, Pieter Vandenbulcke, Josep M. Borràs, Monique J. Roobol, Pim J. van Leeuwen
Publikováno v:
International Journal of Cancer. 142:741-746
The European Randomised Study of Screening for Prostate Cancer (ERSPC) showed that Prostate-Specific Antigen (PSA) based screening results in a significant prostate cancer mortality reduction. Although there are concerns on overdiagnosis and overtrea
Autor:
Alexander Tsodikov, Harry J. de Koning, Tiago M. de Carvalho, Roman Gulati, Eveline A.M. Heijnsdijk, Ruth Etzioni, Angela B. Mariotto, Rachel Hunter-Merrill
Publikováno v:
Cancer. 123:2312-2319
BACKGROUND: Black men in the United States have substantially higher prostate cancer incidence rates than the general population. The extent to which this incidence disparity is because prostate cancer is more prevalent, more aggressive, and/or more
Publikováno v:
Prostate, 77(9), 962-969. Wiley-Liss Inc.
BACKGROUND: A significant proportion of screen-detected men with prostate cancer may be overdiagnosed. Active Surveillance (AS) has emerged as a way to mitigate this problem, by delaying treatment of men, who are at low-risk until this becomes necess
Publikováno v:
Medical Decision Making, 39(4), 405-413. SAGE Publishing
Med Decis Making
Med Decis Making
Background. Microsimulation models have been extensively used in the field of cancer modeling. However, there is substantial uncertainty regarding estimates from these models, for example, overdiagnosis in prostate cancer. This is usually not thoroug
UNSTRUCTURED Skin cancer is a growing public health problem. Early and accurate detection is important, since prognosis and cost of treatment are highly dependent on cancer stage at detection. However, access to specialized health care professionals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b88de84fbc91acf2bcbb41d4cb14d557
https://doi.org/10.2196/preprints.13376
https://doi.org/10.2196/preprints.13376